Ionis Pharmaceuticals (IONS) PT Raised to $63 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Justin Kim raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $63.00 (from $61.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
